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Background
Chagas disease, also known as American
Trypanosomiasis, is endemic in the Americas,
especially Central and South America. Chagas disease
is a zoonotic disease caused by the parasite
Trypanosoma cruzi. Most of the infections take place
in children by vector or congenital transmission, with
other modes of infection such as blood transfusion,
organ transplants, and oral route being less frequent. In
areas under vectorial control, congenital transmission
is the most common way of accruing the disease 1.
The important population migratory movements of
the last decades have significantly impacted public
health. People migrate not just with their culture,
beliefs and hopes, but also with their health problems.
Many diseases, such as Chagas disease, can thus be
transferred to new regions and progress silently due to
lack of knowledge of the local health system, and
eventually produce autochthonous cases.
Vector transmission of the disease takes place
mostly in rural areas. In Argentina, this is limited to
the north of the country, in the provinces of Santiago
del Estero, Chaco, Formosa, Corrientes, Santa Fe,
Tucumán, and Salta, with isolated cases also reported
in the rural areas of Cordoba and Mendoza. In areas
where vectors are better controlled, congenital
infection has become the main route of transmission.
The City of Buenos Aires is not currently an endemic
area for the vector.
In 1991, the World Health Organization (WHO)
promoted a plan to control the vector and to screen
blood donors. This project, called the “South Cone

Initiative”, led to a marked decrease in vector and
blood-borne transmission.
The Pan-American Health Organization (PAHO)
estimates that there are currently 1,600,000 infected
people in Argentina, and approximately 1,000 new
congenital infections every year i. Prevalence of
Chagas disease in pregnant women in Latin America
ranges from 5% to 40% depending on geographical
area, and the rate of congenital transmission is
estimated to be 4% to 10%. An infected mother can
have several infected children, as vertical transmission
of the infection can take place in either the acute or
chronic stage.
Recently, migratory flows have changed the
epidemiological landscape of Chagas disease from
predominantly rural areas to a prevalent urban setting.
It is estimated that most infected patients currently live
in large cities. Also, migration has led to Chagas
disease cases being described in non-endemic regions
such as European countries (e.g., Spain, France,
Switzerland), United States of America, Australia and
even Japan, among others 2. As previously
mentioned, an important consequence of these
movements of infected people outside the geographic
area of the vector is that, currently, most of the new
cases are due to congenital infection 2,3.
According to the 2010 Argentine National Census,
over 53% of the population of Argentina lives in
urbanized areas of the Province of Buenos Aires and
the City of Buenos Aires, a non-endemic region for the
vector. The City of Buenos Aires in particular has
received a large flow of migrants from the north of the
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country and from neighboring countries with a high
prevalence of infection such as Bolivia, Paraguay and
Peru 2. Argentina harbors 550,713 Paraguayan
citizens, 345,272 Bolivians, and 157,514 Peruvians.
From this migrant population, 85.9% of Paraguayans,
65% of Bolivians, and 82.4% of Peruvians live in
urbanized areas of the Province of Buenos Aires and
the City of Buenos Aires 5.
The relatively high birth rates of these populations
may explain the increase in congenital cases observed
in the last decade 2. It has been estimated that
approximately 1,000 to 1,300 infected children are
born every year in Argentina 1,2]. According to the
Argentine National Chagas Program, of the 22,798
births in 2010 reported in the City of Buenos Aires,
3.4% were from mothers infected with chronic Chagas
disease. Forty-one percent of these mothers were
originally from the north of Argentina (mostly from
the endemic provinces of Santiago del Estero and
Chaco), 29% from Bolivia, 18% from Paraguay, and
9% from Peru.However, the actual prevalence of
Chagas disease in the City of Buenos Aires has not
been thoroughly studied 2.
The study
Between 2005 and 2009 we performed a
multicenter prevalence study of Chagas disease in
primary care centers of the City of Buenos Aires.
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These centers (Neighborhoods 1, 7 and 9) are staffed
by multidisciplinary health teams that cater to the
health needs of low-income areas of the city where
many newcomers live (Figure).
The target population of these centers in these
neighborhoods includes over 200,000 people. A total
of 1,786 subjects were included in the study.
Demographic data including age, origin, place of birth,
travel history and family structure were collected for
all included patients. The study was approved by the
Ethics and Research Review Boards, Buenos Aires
Children´s Hospital “R Gutierrez”, Argentina. Written
informed consent was obtained from the patients or the
patients' legal representatives, as appropriate.
Results
We observed a prevalence of 4.3% of Chagas
disease infection in the population studied (n: 1786).
Over half of the subjects in the study were female
(68.6%); the median age was 19.2 years (range 8
months to 40 years), with 73% younger than 20 years
old. Approximately 60% were Argentine, 17%
Bolivian, 12% Peruvian, and 10% Paraguayan. The
main risk factors for infection were the following:
having a family member with Chagas disease, being
familiar with the vector (i.e., stating to know how to
identify the vector), being born in Bolivia, and, in
those from Argentina, being born in the province of

Figure. Migrant population growth in the areas examined in our study between 2001 and 2010
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Santiago del Estero.
We also observed higher infection prevalence in
school-age children than previously reported 6 in
other areas of the city, likely due to the characteristics
of the studied population, with a low percentage of
immigrants from endemic areas.
Our study allowed for the identification and
treatment of seven children with congenital infection.
Treatment with benznidazole was well tolerated, and
led to therapeutic response in all children.
The Parasitology and Chagas Service at “Ricardo
Gutierrez” Children’s Hospital in Buenos Aires,
Argentina, is a referral center for Chagas disease with
over 1,500 annual consultations, and approximately
650 children are currently being treated or under
follow-up care for the disease. The mothers of these
children were born in Argentina (57%), Bolivia
(36.5%), and Brazil (6.5%). Approximately 50% of
the mothers born in Argentina (194/370) came from
endemic regions in the country. Sixteen percent of
Argentine mothers were originally from the City of
Buenos Aires and had never visited endemic areas nor
received transfusions, making congenital transmission
the most likely route of infection, and their infected
children the second generation of congenital infection.
Conclusion
The majority of new Chagas disease cases
originate in the City of Buenos Aires by vertical
transmission. Many infections are actually secondgeneration congenital cases, meaning that their
mothers were themselves congenital cases. These
findings highlight the fact that active screening for
Chagas disease in urban settings should be considered
an important component of childhood screening
programs, particularly taking into account the high rate
of pediatric response to treatment 2,3.
An undiagnosed individual with Chagas disease
can eventually become a blood donor or, in the case of
women, give birth to children with congenital
infections, thus perpetuating the cycle of infection in
non-endemic areas.
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